ストックスクリーナーアプリを入手
4.345
9.10%
-0.435
プレマーケット:
4.35
0.005
+0.12%
前日終値:
$4.78
開ける：
$4.77
24時間の取引高:
1.97M
Relative Volume:
0.93
時価総額：
$727.28M
収益：
$25.55M
当期純損益:
$-341.97M
株価収益率:
-1.5518
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
-5.95%
1か月 パフォーマンス:
-7.75%
6か月 パフォーマンス:
-47.27%
1年 パフォーマンス:
-60.50%
1日の値動き範囲:
$4.24
$4.85
1週間の範囲:
$4.00
$5.99
52週間の値動き範囲:
$4.00
$11.16
Relay Therapeutics Inc Stock (RLAY) Company Profile
RLAY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
4.345 | 727.28M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.66 | 106.01B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
690.87 | 75.92B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.60 | 39.80B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
240.51 | 31.02B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
112.43 | 26.95B | 3.30B | -501.07M | 1.03B | -2.1146 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-10 | 再開されました | Goldman | Buy |
| 2024-09-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-09-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
| 2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 開始されました | Raymond James | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-09-30 | 開始されました | Barclays | Equal Weight |
| 2022-09-02 | 開始されました | Stifel | Buy |
| 2022-06-06 | 開始されました | Jefferies | Underperform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-07-21 | 開始されました | BofA Securities | Buy |
| 2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-10 | 開始されました | Cowen | Outperform |
| 2020-08-10 | 開始されました | Goldman | Buy |
| 2020-08-10 | 開始されました | Guggenheim | Buy |
| 2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
Relay Therapeutics (NASDAQ:RLAY) Shares Down 4.8%Here's Why - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Given "Buy" Rating at HC Wainwright - MarketBeat
Relay Therapeutics Highlights Progress at Healthcare Conference - TipRanks
Barclays PLC Grows Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Barclays PLC Purchases 136,541 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Relay Therapeutics stock hits 52-week low at $4 By Investing.com - Investing.com South Africa
Relay Therapeutics (NASDAQ:RLAY) Hits New 12-Month LowShould You Sell? - MarketBeat
Relay Therapeutics stock hits 52-week low at $4 - Investing.com India
Eli Lilly in talks to acquire Scorpion Therapeutics, FT says; Relay Therapeutics seesaws - MSN
Eli Lilly in talks to acquire Scorpion Therapeutics, FT says; Relay Therapeutics seesaws (LLY:NYSE) - Seeking Alpha
Relay Therapeutics Chief Corporate Development Officer Peter Rahmer Sells 63% Of Holding - Simply Wall St
Relay Therapeutics (NASDAQ:RLAY) Stock Price Up 4.8%Should You Buy? - MarketBeat
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Relay Therapeutics officer sells shares worth $345,571 By Investing.com - Investing.com Australia
Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Sells $73,763.20 in Stock - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) Insider Peter Rahmer Sells 32,156 Shares - MarketBeat
Relay Therapeutics officer sells shares worth $345,571 - Investing.com
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Grows Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Layoff Tracker: Regeneron Acquisition of Oxular Wipes Out Oxular Workforce - BioSpace
Relay Therapeutics stock hits 52-week low at $4.11 amid market challenges - Investing.com Australia
Relay Therapeutics president sells shares for $2,877 By Investing.com - Investing.com Australia
Relay Therapeutics’ chief corporate development officer sells $1,752 in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics' chief corporate development officer sells $1,752 in stock By Investing.com - Investing.com Australia
Relay Therapeutics president sells shares for $2,877 - Investing.com India
Relay Therapeutics' chief corporate development officer sells $1,752 in stock - Investing.com India
Relay Therapeutics chief legal officer sells $1,309 in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics chief legal officer sells $1,309 in stock - Investing.com India
Thomas Catinazzo Sells 4,865 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics CFO sells $21,490 in stock By Investing.com - Investing.com Nigeria
Relay Therapeutics CFO sells $21,490 in stock - Investing.com
Relay Therapeutics stock hits 52-week low at $4.11 amid market challenges By Investing.com - Investing.com South Africa
Relay Therapeutics (NASDAQ:RLAY) Sets New 52-Week LowTime to Sell? - MarketBeat
Is Relay Therapeutics (RLAY) the Best Biotech Penny Stock to Invest in Now? - Insider Monkey
12 Best Biotech Penny Stocks To Invest In Now - Insider Monkey
Jane Street Group LLC Trims Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock Holdings Increased by Geode Capital Management LLC - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Purchased by Geode Capital Management LLC - MarketBeat
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by Barclays PLC - MarketBeat
Barclays PLC Acquires 136,541 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
0.13%
0.37%
大文字化:
|
ボリューム (24 時間):